Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress [Yahoo! Finance]
Daxor Corporation - Closed End Fund (DXR)
NASDAQ:AMEX Investor Relations:
daxor.com/investors
Company Research
Source: Yahoo! Finance
announces it will be exhibiting at the Society for Critical Care Medicine (SCCM) 2024 Critical Care Congress at the Phoenix Convention Center in Phoenix, AZ from January 21 through January 23, 2024. Highlighting the significance of this meeting as the leading critical care conference globally and presenting a substantial opportunity for Daxor to extend its presence within this specialized field, Michael Feldschuh, Daxor's CEO and President, said, “Our diagnostic has shown its value in guiding care to optimal volume in areas such as heart failure and critical care. This conference allows us to reach providers and healthcare systems for whom effective volume management poses a significant challenge, and stand to benefit from both a patient outcome and health economic perspective by adopting our solutions.” Daxor's Chief Scientific Officer Jonathan Feldschuh added, "We have demonstrated compelling evidence affirming the efficacy of direct blood volume measurement in enhancing patient
Show less
Read more
Impact Snapshot
Event Time:
DXR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXR alerts
High impacting Daxor Corporation - Closed End Fund news events
Weekly update
A roundup of the hottest topics
DXR
News
- New Studies Prove the Clinical Benefits of Daxor's Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion [Yahoo! Finance]Yahoo! Finance
- New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of CongestionGlobeNewswire
- DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING'24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR'S BLOOD VOLUME DIAGNOSTIC (BVA-100™) [Yahoo! Finance]Yahoo! Finance
- DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)GlobeNewswire
- Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital [Yahoo! Finance]Yahoo! Finance
DXR
Sec Filings
- 4/3/24 - Form 40-17F2
- 4/3/24 - Form 40-17F2
- 4/3/24 - Form 40-17F2
- DXR's page on the SEC website